Drug Profile
Oxymetazoline hydrochloride - RVL Pharmaceuticals
Alternative Names: Oxymetazoline hydrochloride ophthalmic solution; RVL-1201; STN-1013800; UpneeqLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator RevitaLid
- Developer RVL Pharmaceuticals; Santen Pharmaceutical
- Class Eye disorder therapies; Imidazoles; Small molecules
- Mechanism of Action Alpha adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Blepharoptosis